STSA
Satsuma Pharmaceuticals Inc

2,261
Mkt Cap
$36.47M
Volume
0.00
52W High
$8.08
52W Low
$0.59
PE Ratio
-0.55
STSA Fundamentals
Price
$1.10
Prev Close
$1.11
Open
$1.09
50D MA
$0.9776
Beta
1.75
Avg. Volume
460,323.73
EPS (Annual)
-$2.00
P/B
0.97
EV/EBITDA
0.34
Loading...
Loading...
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product for the treatment of migraine. Its product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate, or DHE, which can be self-administered with a pre-filled, single-use, nasal delivery device.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Satsuma Pharmaceuticals Inc?
What is the 52-week high for Satsuma Pharmaceuticals Inc?
What is the 52-week low for Satsuma Pharmaceuticals Inc?
What is Satsuma Pharmaceuticals Inc stock price today?
What was Satsuma Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Satsuma Pharmaceuticals Inc?
What is the Price-to-Book ratio of Satsuma Pharmaceuticals Inc?
What is Satsuma Pharmaceuticals Inc's EBITDA?
What is the 50-day moving average of Satsuma Pharmaceuticals Inc?

Latest STSA News

View
No STSA news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.